However, leptin and insulin resistance caused by obesity result in reduced efficacy of satiety hormones like peptide YY and cholecystokinin over time, ultimately leading to decreased fullness (Guyenet and Schwartz, 2012; Barakat et al., 2024). The gene discussed is PYY; the disease is obesity due to melanocortin 4 receptor deficiency.